✦ LIBER ✦

P1300 EFFICACY AND SAFETY OF DACLATASVIR IN COMBINATION WITH ASUNAPREVIR (DCV+ASV) IN CIRRHOTIC AND NON-CIRRHOTIC PATIENTS WITH HCV GENOTYPE 1B: RESULTS OF THE HALLMARK DUAL STUDY

✍ Scribed by Kao, J.-H.; Heo, J.; Yoffe, B.; Sievert, W.; Jacobson, I.; Bessone, F.; Peng, C.-Y.; Roberts, S.; Yoon, K.T.; Kopit, J.; Linaberry, M.; Noviello, S.; Hughes, E.; Manns, M.

Book ID: 122257038
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 129 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)61467-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P1234 SAFETY AND EFFICACY OF MK-5172 PLU

P1234 SAFETY AND EFFICACY OF MK-5172 PLUS PEGINTERFERON ALFA-2b AND RIBAVIRIN (PR) IN CIRRHOTIC AND NON-CIRRHOTIC TREATMENT-NAIVE PATIENTS WITH HEPATITIS C VIRUS (HCV) GENOTYPE (G)1 INFECTION

✍ Hezode, C.; Bruno, S.; Jacobson, I.; Serfaty, L.; Kwo, P.; Zhou, A.; Gilbert, C. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 60 KB

T-27 Efficacy and safety of telaprevir-b

T-27 Efficacy and safety of telaprevir-based regimens in cirrhotic patients with HCV genotype 1 and prior peginterferon/ribavirin treatment failure: subanalysis of the REALIZE Phase III study

✍ P. Andreone; S. Pol; S. Roberts; Z. Younossi; M. Diago; E.J. Lawitz; R. Focaccia 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB

O10 SAFETY AND EFFICACY OF THE ALL-ORAL

O10 SAFETY AND EFFICACY OF THE ALL-ORAL REGIMEN OF MK-5172/MK-8742 ± RIBAVIRIN IN TREATMENT-NAIVE, NON-CIRRHOTIC, PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 INFECTION: THE C-WORTHY STUDY

✍ Hezode, C.; Serfaty, L.; Vierling, J.M.; Kugelmas, M.; Pearlman, B.; Sievert, W. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Efficacy of endoscopic sclerotherapy on

Efficacy of endoscopic sclerotherapy on long-term management of oesophageal varices: A comparative study of results in patients with cirrhosis of the liver, non-cirrhotic portal fibrosis (NCPF) and extrahepatic portal venous obstruction (EHO)

✍ D. K. BHARGAVA; S. DASARATHY; K. R. SUNDARAM; R. K. AHUJA 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB

40 KDA peginterferon alfa-2A (PEGASYS®)

40 KDA peginterferon alfa-2A (PEGASYS®) in combination with ribavirin in African American and Caucasian patients with HCV genotype 1: a preliminary report of a comparative, multicenter, efficacy and safety study: Lennox J Jeffers, Miami VA Medical Center, Miami, FL; William Cassidy, Louisiana State University Health Sciences Center, Baton Rouge, LA; Charles Howell, University of Maryland School of Medicine, Baltimore, MD; K. Rajender Reddy, University of Miami School of Medicine, Miami, FL; Michael Fallon, University of Alabama, Birmingham, AL; Michael Dragutsky, Gastroenterology Center of the MidSouth, PC, Memphis, TN; George E Harb, Talia Biran, Roche Laboratories Inc, Nutley, NJ

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB